Ratings by Jefferies (Roger Song)
| Date | Company | Symbol | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 8/31/2026 | Protagonist Therapeutics | PTGX | Maintain | Buy (N/A) |
|
Details | ||
| 8/13/2026 | Inovio Pharmaceuticals | INO | Upgrade | Buy (Hold) |
0.77 (1.33) |
72.73% | Details | |
| 7/31/2026 | BioAge Labs Inc | BIOA | Maintain | Buy (N/A) |
|
Details | ||
| 7/9/2026 | United Therapeutics Corp. | UTHR | Maintain | Buy (N/A) |
|
Details | ||
| 6/15/2026 | SAB Biotherapeutics | SABS | Maintain | Buy (N/A) |
|
Details | ||
| 6/8/2026 | Nurix | NRIX | Maintain | Buy (N/A) |
|
Details | ||
| 6/8/2026 | Nurix | NRIX | Maintain | Buy (N/A) |
|
Details | ||
| 6/3/2026 | Cabaletta Bio | CABA | Maintain | Buy (N/A) |
|
Details | ||
| 5/25/2026 | Avalyn Pharma | AVLN | New Coverage | Buy (N/A) |
28.41 (35.28) |
24.18% | Details | |
| 5/20/2026 | SAB Biotherapeutics | SABS | New Coverage | Buy (N/A) |
3.56 (3.70) |
3.93% | Details | |
| 5/19/2026 | Fate Therapeutics | FATE | New Coverage | Buy (N/A) |
1.73 (2.43) |
40.46% | Details | |
| 5/12/2026 | Prelude Therapeutics | PRLD | Maintain | Buy (N/A) |
|
Details | ||
| 5/12/2026 | Kailera Therapeutics | KLRA | New Coverage | Buy (N/A) |
21.47 (16.41) |
-23.57% | Details | |
| 5/4/2026 | Krystal Biotech | KRYS | Maintain | Buy (N/A) |
|
Details | ||
| 4/30/2026 | Veradermics | MANE | Maintain | Buy (N/A) |
|
Details | ||
| 4/28/2026 | Kiniksa | KNSA | Maintain | Buy (N/A) |
|
Details | ||
| 4/27/2026 | Oruka Therapeutics | ORKA | Maintain | Buy (N/A) |
|
Details | ||
| 4/22/2026 | Nektar Therapeutics | NKTR | Maintain | Buy (N/A) |
|
Details | ||
| 4/21/2026 | Veradermics | MANE | Maintain | Buy (N/A) |
|
Details | ||
| 4/21/2026 | BioAge Labs Inc | BIOA | Maintain | Buy (N/A) |
|
Details | ||
| 4/20/2026 | Nektar Therapeutics | NKTR | Maintain | Buy (N/A) |
|
Details | ||
| 4/15/2026 | Allogene | ALLO | Maintain | Buy (N/A) |
|
Details | ||
| 4/14/2026 | Protagonist Therapeutics | PTGX | Maintain | Buy (N/A) |
|
Details | ||
| 4/13/2026 | Allogene | ALLO | Maintain | Buy (N/A) |
|
Details | ||
| 4/13/2026 | Replimune Group | REPL | Downgrade | Hold (Buy) |
5.91 (15.67) |
165.14% | Details | |
| 4/10/2026 | Allogene | ALLO | New Coverage | Buy (N/A) |
2.70 (1.99) |
-26.3% | Details | |
| 3/30/2026 | United Therapeutics Corp. | UTHR | Maintain | Buy (N/A) |
|
Details | ||
| 3/30/2026 | United Therapeutics Corp. | UTHR | Maintain | Buy (N/A) |
|
Details | ||
| 3/30/2026 | United Therapeutics Corp. | UTHR | Maintain | Buy (N/A) |
|
Details | ||
| 3/27/2026 | Cabaletta Bio Inc. | CABA | Maintain | Buy (N/A) |
|
Details | ||
| 3/27/2026 | Altimmune | ALT | Maintain | Buy (N/A) |
|
Details | ||
| 3/26/2026 | WAVE Life Sciences | WVE | Maintain | Buy (N/A) |
|
Details | ||
| 3/26/2026 | Veradermics | MANE | Maintain | Buy (N/A) |
|
Details | ||
| 3/26/2026 | WAVE Life Sciences | WVE | Maintain | Buy (N/A) |
|
Details | ||
| 3/25/2026 | WAVE Life Sciences | WVE | Maintain | Buy (N/A) |
|
Details | ||
| 3/24/2026 | BioAge Labs Inc | BIOA | Maintain | Buy (N/A) |
|
Details | ||
| 3/24/2026 | CytomX Therapeutics | CTMX | Maintain | Buy (N/A) |
|
Details | ||
| 3/23/2026 | Cabaletta Bio Inc. | CABA | Maintain | Buy (N/A) |
|
Details | ||
| 3/18/2026 | Protagonist Therapeutics | PTGX | Maintain | Buy (N/A) |
|
Details | ||
| 3/18/2026 | CytomX Therapeutics | CTMX | Maintain | Buy (N/A) |
|
Details | ||
| 3/12/2026 | Novavax | NVAX | Maintain | Buy (N/A) |
|
Details | ||
| 3/12/2026 | Viking Therapeutic | VKTX | Maintain | Buy (N/A) |
|
Details | ||
| 3/10/2026 | Vaxcyte | PCVX | Maintain | Buy (N/A) |
|
Details | ||
| 3/6/2026 | aTyr Pharma | ATYR | Maintain | Buy (N/A) |
|
Details | ||
| 3/2/2026 | Acrivon Therapeutics Inc | ACRV | Maintain | Buy (N/A) |
|
Details | ||
| 3/2/2026 | Veradermics | MANE | New Coverage | Buy (N/A) |
42.91 (97.51) |
127.24% | Details | |
| 2/18/2026 | BioAge Labs Inc | BIOA | Upgrade | Buy (Hold) |
19.63 (9.52) |
-51.5% | Details | |
| 2/17/2026 | Krystal Biotech | KRYS | Maintain | Buy (N/A) |
|
Details | ||
| 2/2/2026 | Protagonist Therapeutics | PTGX | Maintain | Buy (N/A) |
|
Details | ||
| 1/22/2026 | Corvus Pharmaceuticals | CRVS | Maintain | Buy (N/A) |
|
Details | ||
| 1/9/2026 | Krystal Biotech | KRYS | Maintain | Buy (N/A) |
|
Details | ||
| 1/6/2026 | Aclaris Therapeutis | ACRS | Maintain | Buy (N/A) |
|
Details | ||
| 1/6/2026 | Zenas Biopharma | ZBIO | Maintain | Buy (N/A) |
|
Details | ||
| 12/30/2025 | Inovio Pharmaceuticals | INO | Maintain | Hold (N/A) |
|
Details | ||
| 12/23/2025 | Zenas Biopharma | ZBIO | Maintain | Buy (N/A) |
|
Details | ||
| 12/19/2025 | Disc Medicine | IRON | Maintain | Buy (N/A) |
|
Details | ||
| 12/17/2025 | Nektar Therapeutics | NKTR | Maintain | Buy (N/A) |
|
Details | ||
| 12/12/2025 | WAVE Life Sciences | WVE | Maintain | Buy (N/A) |
|
Details | ||
| 12/9/2025 | Vaxcyte | PCVX | Maintain | Buy (N/A) |
|
Details | ||
| 12/8/2025 | Structure Therapeutics | GPCR | Maintain | Buy (N/A) |
|
Details | ||
| 11/28/2025 | Disc Medicine | IRON | Maintain | Buy (N/A) |
|
Details | ||
| 11/24/2025 | Nektar Therapeutics | NKTR | Maintain | Buy (N/A) |
|
Details | ||
| 11/20/2025 | Disc Medicine | IRON | Maintain | Buy (N/A) |
|
Details | ||
| 11/20/2025 | Kura Oncology | KURA | Maintain | Buy (N/A) |
|
Details | ||
| 11/20/2025 | Nuvalent | NUVL | Maintain | Buy (N/A) |
|
Details | ||
| 11/20/2025 | MBX Biosciences Inc | MBX | Maintain | Buy (N/A) |
|
Details | ||
| 11/20/2025 | Protagonist Therapeutics | PTGX | Maintain | Buy (N/A) |
|
Details | ||
| 11/20/2025 | Whitehawk Therapeutics | WHWK | Maintain | Hold (N/A) |
|
Details | ||
| 11/20/2025 | ALX Oncology | ALXO | Maintain | Buy (N/A) |
|
Details | ||
| 11/13/2025 | ALX Oncology | ALXO | New Coverage | Buy (N/A) |
1.28 (1.98) |
54.69% | Details | |
| 11/13/2025 | Oruka Therapeutics | ORKA | New Coverage | Buy (N/A) |
28.20 (92.11) |
226.63% | Details | |
| 10/27/2025 | Zenas Biopharma | ZBIO | Maintain | Buy (N/A) |
|
Details | ||
| 10/10/2025 | Cabaletta Bio Inc. | CABA | New Coverage | Buy (N/A) |
2.85 (3.30) |
15.79% | Details | |
| 10/10/2025 | Gyre Therapeutics | GYRE | New Coverage | Buy (N/A) |
7.15 (6.47) |
-9.51% | Details | |
| 9/18/2025 | Nektar Therapeutics | NKTR | Maintain | Buy (N/A) |
|
Details | ||
| 9/9/2025 | Tourmaline Bio | TRML | Downgrade | Hold (Buy) |
30.18 (47.98) |
58.98% | Details | |
| 9/9/2025 | Sutro Biopharma | STRO | Maintain | Buy (N/A) |
|
Details | ||
| 8/28/2025 | Biomea Fusion Inc. | BMEA | New Coverage | Buy (N/A) |
1.86 (1.80) |
-3.23% | Details | |
| 8/22/2025 | aTyr Pharma | ATYR | Maintain | Buy (N/A) |
|
Details | ||
| 8/20/2025 | Equillium | EQ | Maintain | Buy (N/A) |
|
Details | ||
| 8/19/2025 | Viking Therapeutic | VKTX | Maintain | Buy (N/A) |
|
Details | ||
| 8/15/2025 | MBX Biosciences Inc | MBX | New Coverage | Buy (N/A) |
13.21 (60.93) |
361.24% | Details | |
| 8/13/2025 | Inovio Pharmaceuticals | INO | Maintain | Buy (N/A) |
|
Details | ||
| 8/11/2025 | Replimune Group | REPL | Maintain | Buy (N/A) |
|
Details | ||
| 8/5/2025 | Lava Therapeutics NV | LVTX | Downgrade | Hold (Buy) |
1.42 (1.74) |
22.54% | Details | |
| 7/29/2025 | Kiniksa | KNSA | Maintain | Buy (N/A) |
|
Details | ||
| 7/22/2025 | Replimune Group | REPL | Maintain | Buy (N/A) |
|
Details | ||
| 6/24/2025 | Nektar Therapeutics | NKTR | Maintain | Buy (N/A) |
|
Details | ||
| 6/18/2025 | Verve Therapeutics | VERV | Downgrade | Hold (Buy) |
6.27 (11.13) |
77.51% | Details | |
| 6/13/2025 | CureVac | CVAC | Downgrade | Hold (Buy) |
4.07 (4.66) |
14.5% | Details | |
| 5/29/2025 | BioAge Labs Inc | BIOA | Maintain | Hold (N/A) |
|
Details | ||
| 5/5/2025 | TG Therapeutics | TGTX | Maintain | Buy (N/A) |
|
Details | ||
| 4/11/2025 | Nektar Therapeutics | NKTR | Upgrade | Buy (Hold) |
0.50 (71.75) |
14250% | Details | |
| 4/1/2025 | Akebia Therapeutics | AKBA | New Coverage | Buy (N/A) |
1.91 (0.94) |
-50.79% | Details | |
| 3/31/2025 | Vaxcyte | PCVX | Maintain | Buy (N/A) |
|
Details | ||
| 3/26/2025 | WAVE Life Sciences | WVE | Maintain | Buy (N/A) |
|
Details | ||
| 3/14/2025 | Sutro Biopharma | STRO | Maintain | Buy (N/A) |
|
Details | ||
| 3/14/2025 | Sana Biotechnology | SANA | New Coverage | Buy (N/A) |
2.66 (3.83) |
43.98% | Details | |
| 3/13/2025 | Nektar Therapeutics | NKTR | Maintain | Hold (N/A) |
|
Details | ||
| 3/10/2025 | Protagonist Therapeutics | PTGX | Maintain | Buy (N/A) |
|
Details | ||
| 3/5/2025 | Krystal Biotech | KRYS | New Coverage | Buy (N/A) |
171.83 (363.84) |
111.74% | Details | |
| 2/25/2025 | WAVE Life Sciences | WVE | New Coverage | Buy (N/A) |
10.48 (4.97) |
-52.58% | Details | |
| 1/27/2025 | IO Biotech | IOBT | Maintain | Buy (N/A) |
|
Details | ||
| 1/23/2025 | Protagonist Therapeutics | PTGX | Maintain | Buy (N/A) |
|
Details | ||
| 1/10/2025 | IGM Biosciences | IGMS | Downgrade | Hold (Buy) |
6.20 (1.27) |
-79.52% | Details | |
| 12/9/2024 | BioAge Labs Inc | BIOA | Downgrade | Hold (Buy) |
18.37 (9.52) |
-48.18% | Details | |
| 12/3/2024 | Replimune Group | REPL | Maintain | Buy (N/A) |
|
Details | ||
| 11/27/2024 | Disc Medicine | IRON | Maintain | Buy (N/A) |
|
Details | ||
| 11/21/2024 | Kura Oncology | KURA | Maintain | Buy (N/A) |
|
Details | ||
| 11/19/2024 | Aclaris Therapeutis | ACRS | Upgrade | Buy (Hold) |
2.05 (6.02) |
193.66% | Details | |
| 11/13/2024 | Corvus Pharmaceuticals | CRVS | Maintain | Buy (N/A) |
|
Details | ||
| 11/6/2024 | Vaxcyte | PCVX | Maintain | Buy (N/A) |
|
Details | ||
| 11/4/2024 | Viking Therapeutic | VKTX | Maintain | Buy (Buy) |
|
Details | ||
| 10/23/2024 | Disc Medicine | IRON | New Coverage | Buy (N/A) |
50.77 (78.67) |
54.95% | Details | |
| 10/21/2024 | BioAge Labs Inc | BIOA | New Coverage | Buy (N/A) |
22.99 (18.37) |
-20.1% | Details | |
| 10/16/2024 | Novavax | NVAX | Maintain | Buy (N/A) |
|
Details | ||
| 10/11/2024 | Nurix | NRIX | New Coverage | Buy (N/A) |
21.86 (26.04) |
19.12% | Details | |
| 10/2/2024 | Novavax | NVAX | Maintain | Buy (Buy) |
|
Details | ||
| 10/1/2024 | IGM Biosciences | IGMS | Maintain | Buy (N/A) |
|
Details | ||
| 9/13/2024 | Kiniksa | KNSA | New Coverage | Buy (N/A) |
24.34 (79.28) |
225.72% | Details | |
| 9/10/2024 | Nuvalent | NUVL | Maintain | Buy (N/A) |
|
Details | ||
| 9/5/2024 | aTyr Pharma | ATYR | New Coverage | Buy (N/A) |
1.78 (0.48) |
-73.03% | Details | |
| 9/3/2024 | Vaxcyte | PCVX | Maintain | Buy (N/A) |
|
Details | ||
| 9/3/2024 | Vaxcyte | PCVX | Maintain | Buy (N/A) |
|
Details | ||
| 9/3/2024 | IO Biotech | IOBT | Maintain | Buy (N/A) |
|
Details | ||
| 8/21/2024 | Aadi Bioscience Inc | AADI | Downgrade | Hold (Buy) |
1.62 (2.05) |
26.54% | Details | |
| 7/19/2024 | Novavax | NVAX | Maintain | Buy (N/A) |
|
Details | ||
| 5/10/2024 | Nektar Therapeutics | NKTR | Maintain | Hold (N/A) |
|
Details | ||
| 5/9/2024 | Aadi Bioscience Inc | AADI | Maintain | Buy (N/A) |
|
Details | ||
| 5/6/2024 | CytomX Therapeutics | CTMX | Upgrade | Buy (Hold) |
4.50 (3.67) |
-18.44% | Details | |
| 4/17/2024 | Nuvalent | NUVL | New Coverage | Buy (N/A) |
65.28 (123.96) |
89.89% | Details | |
| 3/20/2024 | Lava Therapeutics NV | LVTX | Maintain | Buy (N/A) |
|
Details | ||
| 3/20/2024 | Tourmaline Bio | TRML | Maintain | Buy (N/A) |
|
Details | ||
| 3/12/2024 | CytomX Therapeutics | CTMX | Maintain | Hold (N/A) |
|
Details | ||
| 3/12/2024 | CytomX Therapeutics | CTMX | Maintain | Hold (N/A) |
|
Details | ||
| 3/7/2024 | Viking Therapeutic | VKTX | New Coverage | Buy (N/A) |
87.90 (33.67) |
-61.7% | Details | |
| 3/5/2024 | Nektar Therapeutics | NKTR | Maintain | Hold (Hold) |
|
Details | ||
| 1/12/2024 | Kura Oncology | KURA | Maintain | Buy (N/A) |
|
Details | ||
| 1/10/2024 | Aclaris Therapeutis | ACRS | Downgrade | Hold (Buy) |
1.28 (2.05) |
60.16% | Details | |
| 12/15/2023 | Aclaris Therapeutis | ACRS | Maintain | Buy (N/A) |
|
Details | ||
| 12/15/2023 | Aadi Bioscience Inc | AADI | Maintain | Buy (N/A) |
|
Details | ||
| 12/15/2023 | Acrivon Therapeutics Inc | ACRV | New Coverage | Buy (N/A) |
5.20 (2.07) |
-60.19% | Details | |
| 12/15/2023 | Tourmaline Bio | TRML | New Coverage | Buy (N/A) |
18.55 (30.18) |
62.7% | Details | |
| 12/12/2023 | Icosavax Inc. | ICVX | Downgrade | Hold (Buy) |
10.49 (15.31) |
45.95% | Details | |
| 11/10/2023 | Inovio Pharmaceuticals | INO | Maintain | Hold (N/A) |
|
Details | ||
| 10/3/2023 | Structure Therapeutics | GPCR | Maintain | Buy (N/A) |
|
Details | ||
| 9/29/2023 | Structure Therapeutics | GPCR | Maintain | Buy (N/A) |
|
Details | ||
| 9/19/2023 | Kinnate Biopharma | KNTE | Maintain | Buy (N/A) |
|
Details | ||
| 6/28/2023 | Protagonist Therapeutics | PTGX | Maintain | Buy (N/A) |
|
Details | ||
| 6/26/2023 | TG Therapeutics | TGTX | New Coverage | Buy (N/A) |
23.60 (56.09) |
137.67% | Details | |
| 6/26/2023 | Protagonist Therapeutics | PTGX | Maintain | Buy (N/A) |
|
Details | ||
| 6/15/2023 | Lava Therapeutics NV | LVTX | Maintain | Buy (N/A) |
|
Details | ||
| 5/25/2023 | Magma Design | LAVA | New Coverage | Buy (N/A) |
7.34 (7.34) |
0% | Details | |
| 5/25/2023 | Omega Therapeutics | OMGA | New Coverage | Buy (N/A) |
9.66 (0.14) |
-98.55% | Details | |
| 5/25/2023 | Protagonist Therapeutics | PTGX | New Coverage | Buy (N/A) |
25.20 (146.49) |
481.31% | Details | |
| 5/25/2023 | Lava Therapeutics NV | LVTX | New Coverage | Buy (N/A) |
1.88 (1.42) |
-24.47% | Details | |
| 5/25/2023 | IO Biotech | IOBT | New Coverage | Buy (N/A) |
2.08 (0.05) |
-97.6% | Details | |
| 5/25/2023 | Structure Therapeutics | GPCR | New Coverage | Buy (N/A) |
26.59 (47.13) |
77.25% | Details | |
| 5/10/2023 | Nektar Therapeutics | NKTR | Upgrade | Hold (Underperform) |
0.77 (0.50) |
-35.06% | Details | |
| 3/31/2023 | IGM Biosciences | IGMS | Maintain | Buy (N/A) |
|
Details | ||
| 3/29/2023 | Aadi Bioscience Inc | AADI | Maintain | Buy (N/A) |
|
Details | ||
| 2/28/2023 | Aclaris Therapeutis | ACRS | Maintain | Buy (N/A) |
|
Details | ||
| 2/27/2023 | Kinnate Biopharma | KNTE | Maintain | Buy (N/A) |
|
Details | ||
| 2/24/2023 | Nektar Therapeutics | NKTR | Downgrade | Underperform (Hold) |
3.01 (71.75) |
2283.72% | Details | |
| 2/13/2023 | Glycomimetics | GLYC | Maintain | Buy (N/A) |
|
Details | ||
| 2/10/2023 | Glycomimetics | GLYC | Maintain | Buy (N/A) |
|
Details | ||
| 11/9/2022 | IGM Biosciences | IGMS | New Coverage | Buy (N/A) |
17.20 (1.27) |
-92.62% | Details | |
| 11/8/2022 | Vaxcyte | PCVX | Maintain | Buy (N/A) |
|
Details | ||
| 10/11/2022 | Novavax | NVAX | Maintain | Buy (N/A) |
|
Details | ||
| 8/31/2022 | Altimmune | ALT | Maintain | Buy (N/A) |
|
Details | ||
| 8/16/2022 | Icosavax Inc. | ICVX | Maintain | Buy (N/A) |
|
Details | ||
| 7/29/2022 | Prelude Therapeutics | PRLD | New Coverage | Buy (N/A) |
5.89 (5.49) |
-6.79% | Details | |
| 7/7/2022 | CytomX Therapeutics | CTMX | Downgrade | Hold (Buy) |
1.97 (3.67) |
86.29% | Details | |
| 5/31/2022 | Nektar Therapeutics | NKTR | New Coverage | Hold (N/A) |
3.54 (71.75) |
1926.84% | Details | |
| 4/28/2022 | Glycomimetics | GLYC | Maintain | Buy (N/A) |
|
Details | ||
| 4/19/2022 | Novavax | NVAX | Maintain | Buy (N/A) |
|
Details | ||
| 4/4/2022 | Finch Therapeutics Group Inc. | FNCH | Maintain | Buy (N/A) |
|
Details | ||
| 3/31/2022 | Replimune Group | REPL | Maintain | Buy (N/A) |
|
Details | ||
| 3/22/2022 | Icosavax Inc. | ICVX | Maintain | Buy (N/A) |
|
Details | ||
| 2/22/2022 | Novavax | NVAX | New Coverage | Buy (N/A) |
81.89 (10.12) |
-87.64% | Details | |
| 2/15/2022 | Kura Oncology | KURA | New Coverage | Buy (N/A) |
12.90 (12.89) |
-0.08% | Details | |
| 1/11/2022 | Aadi Bioscience Inc | AADI | New Coverage | Buy (N/A) |
21.75 (1.62) |
-92.55% | Details | |
| 12/29/2021 | Inovio Pharmaceuticals | INO | New Coverage | Hold (N/A) |
5.72 (0.77) |
-86.54% | Details | |
| 12/29/2021 | Vaxart Inc. | VXRT | New Coverage | Buy (N/A) |
6.69 (0.32) |
-95.22% | Details | |
| 12/29/2021 | VBI Vaccines | VBIV | New Coverage | Buy (N/A) |
2.31 (0.07) |
-96.97% | Details | |
| 12/29/2021 | Vaxxinity | VAXX | New Coverage | Buy (N/A) |
6.37 (0.00) |
-100% | Details | |
| 12/29/2021 | Vaxcyte | PCVX | New Coverage | Buy (N/A) |
23.09 (60.81) |
163.36% | Details | |
| 12/29/2021 | Icosavax Inc. | ICVX | New Coverage | Buy (N/A) |
22.51 (15.31) |
-31.99% | Details | |
| 12/29/2021 | Metacrine Inc. | MTCR | New Coverage | Hold (N/A) |
0.66 (0.49) |
-25.76% | Details | |
| 12/29/2021 | Altimmune | ALT | New Coverage | Buy (N/A) |
8.84 (3.09) |
-65.05% | Details | |
| 12/1/2021 | Corvus Pharmaceuticals | CRVS | New Coverage | Buy (N/A) |
3.45 (14.27) |
313.62% | Details | |
| 11/12/2021 | Glycomimetics | GLYC | Upgrade | Buy (Hold) |
2.02 (0.16) |
-92.08% | Details | |
| 9/27/2021 | Kinnate Biopharma | KNTE | New Coverage | Buy (N/A) |
23.15 (2.65) |
-88.55% | Details | |
| 9/23/2021 | Aclaris Therapeutis | ACRS | Maintain | Buy (N/A) |
|
Details | ||
| 8/30/2021 | Aclaris Therapeutis | ACRS | Maintain | Buy (N/A) |
|
Details | ||
| 7/23/2021 | Aclaris Therapeutis | ACRS | New Coverage | Buy (N/A) |
15.61 (6.02) |
-61.43% | Details | |
| 7/1/2021 | Atreca Inc. | BCEL | Maintain | Buy (N/A) |
|
Details | ||
| 5/18/2021 | Pieris Pharmaceuticals | PIRS | New Coverage | Buy (N/A) |
1.88 (13.60) |
623.4% | Details | |
| 5/18/2021 | Equillium | EQ | New Coverage | Buy (N/A) |
5.42 (2.21) |
-59.23% | Details | |
| 4/29/2021 | Cara Therapeutics | CARA | Maintain | Buy (N/A) |
|
Details | ||
| 4/13/2021 | Finch Therapeutics Group Inc. | FNCH | New Coverage | Buy (N/A) |
17.18 (7.30) |
-57.51% | Details | |
| 4/5/2021 | Molecular Templates | MTEM | Maintain | Buy (N/A) |
|
Details | ||
| 3/23/2021 | CytomX Therapeutics | CTMX | Upgrade | Buy (Hold) |
8.52 (3.67) |
-56.92% | Details | |
| 2/8/2021 | Atreca Inc. | BCEL | New Coverage | Buy (N/A) |
14.93 (0.09) |
-99.4% | Details | |
| 11/2/2020 | Replimune Group | REPL | New Coverage | Buy (N/A) |
43.18 (5.91) |
-86.31% | Details | |
| 9/8/2020 | Molecular Templates | MTEM | New Coverage | Buy (N/A) |
10.26 (0.11) |
-98.93% | Details | |
| 9/2/2020 | Sutro Biopharma | STRO | New Coverage | Buy (N/A) |
10.01 (20.82) |
107.99% | Details | |
| 8/5/2019 | Glycomimetics | GLYC | New Coverage | Hold (Buy) |
9.13 (0.16) |
-98.25% | Details | |
| 1/3/2019 | Aevi | GNMX | Maintain | Hold (N/A) |
|
Details | ||
| 11/2/2018 | Amarin Corporation | AMRN | Maintain | Buy (N/A) |
|
Details | ||
| 10/15/2018 | AcelRx Pharmaceuticals | ACRX | Upgrade | Buy (Hold) |
3.98 (0.86) |
-78.39% | Details |
